⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

Official Title: A Phase 3b, Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety, Tolerability, and Efficacy of Zilucoplan in Participants With Generalized Myasthenia Gravis Switching From Intravenous Complement Component 5 Inhibitors to Subcutaneous Zilucoplan

Study ID: NCT05514873

Study Description

Brief Summary: The purpose of the study is to evaluate the safety and tolerability of switching from intravenous (IV) complement component 5 (C5) inhibitors to subcutaneous (SC) Zilucoplan in study participants with generalized myasthenia gravis (gMG)

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Mg0017 50564, Scottsdale, Arizona, United States

Mg0017 50559, Los Angeles, California, United States

Mg0017 50593, Rancho Mirage, California, United States

Mg0017 50099, San Francisco, California, United States

Mg0017 50557, O'Fallon, Illinois, United States

Mg0017 50556, Chapel Hill, North Carolina, United States

Mg0017 50086, Charlotte, North Carolina, United States

Mg0017 50076, Columbus, Ohio, United States

Mg0017 50555, Austin, Texas, United States

Mg0017 50304, Dallas, Texas, United States

Mg0017 50111, Seattle, Washington, United States

Mg0017 50569, Greenfield, Wisconsin, United States

Contact Details

Name: UCB Cares

Affiliation: 001 844 599 2273

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: